SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-106677
Filing Date
2010-11-17
Accepted
2010-11-17 16:47:38
Documents
9
Period of Report
2010-11-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a57880e8vk.htm 8-K 13514
2 EX-10.1 a57880exv10w1.htm EX-10.1 68336
3 EX-10.2 a57880exv10w2.htm EX-10.2 71371
4 EX-10.3 a57880exv10w3.htm EX-10.3 72366
5 EX-10.4 a57880exv10w4.htm EX-10.4 62718
6 GRAPHIC a57880a5788000.gif GRAPHIC 9101
7 GRAPHIC a57880a5788001.gif GRAPHIC 7190
8 GRAPHIC a57880a5788002.gif GRAPHIC 10228
9 GRAPHIC a57880a5788003.gif GRAPHIC 10228
  Complete submission text file 0000950123-10-106677.txt   341412
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 101200266
SIC: 2834 Pharmaceutical Preparations